Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of homoharringtonine and interferon alfa in
treating patients with chronic myelogenous leukemia. Drugs used in chemotherapy use different
ways to stop cancer cells from dividing so they stop growing or die. Interferon alfa may
interfere with the growth of cancer cells. Combining chemotherapy with interferon alfa may
kill more cancer cells.